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practice of radiosurgery has grown and evolved with the
introduction of new technologies and the involvement of
other disciplines. Currently, radiosurgery practices involve
neurosurgery, radiation oncology, medical physics and, in
many centers, neuroradiology. Various commercially
available radiosurgical devices are used, including the
conventional linear accelerator, CyberKnife, Gamma Knife,
and even particle therapy units.
The historical roots of each radiosurgery practice affect
the terminology and procedures applied for treatment
planning and delivery, resulting in wide variability in image
acquisition, planning, and verification practices across the
community. This organic development has led to a
“confusion of tongues,” challenging our ability to interpret
the published scientific literature in a meaningful way and
hindering the radiosurgery community’s ability to collab-
orate effectively to advance the science and practice of
radiosurgery.
The broader radiation therapy literature contains a
growing body of evidence that the quality of radiation
delivery has a significant impact on clinical outcomes. This
was highlighted in a secondary report of a large multicenter
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http://dx.doi.org/10.1016/j.ijrobp.2014.12.062significantly worse survival when greater deficiencies were
found during the central quality assurance review of the
radiation therapy plans (1). Particularly for radiosurgery, a
high-precision treatment delivered over a single or few
fractions, the quality of treatment planning and delivery is
likely to have an even greater impact.
The recent publication from Quantitative Analyses of
Normal Tissue Effects in the Clinic provided a landscape of
our understanding of normal tissue tolerances to radiation.
However, this report largely summarized the tissue toler-
ances observed for conventionally fractionated radiation
therapy, and it was emphasized that tissue tolerances in the
setting of treatments with large dose per fraction, as used in
radiosurgery, are largely unknown. Although the number of
radiosurgery publications has risen exponentially over recent
years, the variability in reporting dosimetric data, treatment
response, and toxicity data has hindered meaningful sys-
tematic reviews or meta-analyses. To perform meaningful,
quantitative measurements of the impact of quality on our
outcomes across institutions, we need standardized termi-
nology for reporting radiosurgery planning parameters and
standardized delineation of organs at risk (OAR). Variability
in our target and OAR delineation practices and reporting of
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across institutions and the published literature.
The authors of this article are excited by the trans-
formation that is emerging in the collective radiosurgery
community. The International Leksell Gamma Knife
Society (LGKS) recently created a standardization com-
mittee that worked with society members to establish rec-
ommendations for uniform terminology and standardized
dose reporting for radiosurgery that are better harmonized
with the current recommendations of the International
Commission on Radiation Units and Measurements (ICRU)
(2). In parallel, the ICRU is preparing updated recom-
mendations for standardized reporting of small field treat-
ments, including radiosurgery. The LGKS and the
International Society of Stereotactic Radiosurgery are
supporting a unified effort to standardize the reporting of
radiosurgery treatments and outcomes through collabora-
tion on standardized OAR definitions. An effort by the
radiosurgery community through the American Association
of Neurological Surgeons and the American Society for
Radiation Oncology has recently been launched to gather
data in a national registry for stereotactic radiosurgery.These larger group efforts are helping resolve our
confusion of tongues, but the diligent action of each and
every member of the radiosurgery community to apply the
new standardized terminology and to use standardized dose
and outcome reporting is critical to the successful imple-
mentation of these efforts. Let us ensure that we continue to
innovate and improve treatment for our patients by taking
advantage of this transformative movement that has unified
our growing multidisciplinary radiosurgery community.References
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